Role change
Lynn F. White
Lead Independent Director
LXU ·
LSB INDUSTRIES, INC.
Lynn F. White to serve as Lead Independent Director
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8051–8100 of 35180
Lynn F. White to serve as Lead Independent Director
On August 8, 2024, the board of directors (the “ Board ”) of Sutro Biopharma, Inc. (the “ Company ”) appointed Sukhi Jagpal, as a Class III director, effective as of August 8, 2024, and as a member of the Audit Committee, effective as of August 15, 2024.
On August 12, 2024, the Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”), acting upon the recommendation of its Nominating and Corporate Governance Committee, appointed Manish H. Shah, age 60, and Amit Singhi, age 59, to the Board, effective August 12, 2024.
On August 12, 2024, the Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”), acting upon the recommendation of its Nominating and Corporate Governance Committee, appointed Manish H. Shah, age 60, and Amit Singhi, age 59, to the Board, effective August 12, 2024.
the Board of Directors of Eaton Corporation plc (the “Company”) expanded its size to eleven members and elected Paulo Ruiz to the Board, effective September 2, 2024.
On August 8, 2024, each of Thomas Sullivan, Jason Delves and Jill Witter (collectively, the “ F9 Directors ”) delivered notice of their respective resignation as a member of the Board effective immediately.
On August 8, 2024, each of Thomas Sullivan, Jason Delves and Jill Witter (collectively, the “ F9 Directors ”) delivered notice of their respective resignation as a member of the Board effective immediately.
On August 8, 2024, each of Thomas Sullivan, Jason Delves and Jill Witter (collectively, the “ F9 Directors ”) delivered notice of their respective resignation as a member of the Board effective immediately.
Stephen Herbert submitted his resignation from the board of directors of the Company effective immediately.
KBR, Inc. (“KBR”) announced on August 12, 2024, the appointment of Nchacha E. Etta to its Board of Directors effective August 12, 2024.
appointed Wade Oosterman to the Board as a Class II director
the Board of Directors of Pulse Biosciences, Inc. (the “Company”) elected Paul A. LaViolette to serve as a member of the Company’s Board of Directors
with David DeCaprio, Jon Olsen, Greg Lipschitz and Brian Posner to serve on the Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
with David DeCaprio, Jon Olsen, Greg Lipschitz and Brian Posner to serve on the Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
with David DeCaprio, Jon Olsen, Greg Lipschitz and Brian Posner to serve on the Board
with David DeCaprio, Jon Olsen, Greg Lipschitz and Brian Posner to serve on the Board
Effective as of August 9, 2024, the Company expanded the size of the Board to six directors and pursuant to the Board Designation Agreement, appointed Richard Coleman, the Chief Executive Officer of the Star Equity Holdings, Inc., as a director of the Company.
On August 7, 2024, Yvonne Hyland was appointed to the Board of Directors of the Company.
On August 9, 2024, the Board of Directors (the “ Board ”) of Hempacco Co., Inc. (the “ Company ”) appointed Paul Glavine and Harrison Newlands as members of the Board of the Company to fill two vacancies on the Board.
On August 9, 2024, the Board of Directors (the “ Board ”) of Hempacco Co., Inc. (the “ Company ”) appointed Paul Glavine and Harrison Newlands as members of the Board of the Company to fill two vacancies on the Board.
On August 6, 2024, the Board of Directors (the “Board”) of Kingfish Holding Corporation (the “Company”) agreed to expand the size of the Board to seven directors and appointed James Robert Lindsay (Bob Lindsay) as a member of the Board to fill the newly created vacancy.
On August 7, 2024, Mr. Anthony S. Chan tendered his resignation as a member of the board of directors (the “Board”) of Fortune Valley Treasures, Inc., a Nevada corporation (the “Company”), due to personal reasons.
Effective July 29, 2024, the Board appointed Jay Lucas and Bobby Carpenter as Directors of the Company.
Effective July 29, 2024, the Board appointed Jay Lucas and Bobby Carpenter as Directors of the Company.
On July 29, 2024, Sandy Lipkins tendered his resignation as a member of the board of directors (the “Board”) of the Company.
On August 12, 2024, David Natan delivered his resignation as a member of the Company’s Board of Directors, effective immediately.
On August 8, 2024, the Board of Directors (the “Board”) of Wheeler Real Estate Investment Trust, Inc. (the “Company”) voted to elect Rebecca Musser as a director of the Company and to appoint her to the Audit Committee of the Board (the “Audit Committee”), effective as of August 8, 2024, to serve until the Company’s 2025 annual meeting of stockholders.
Effective as of the date of the Agreement, Jason Cohenour and Phu Hoang have agreed not to stand for re-election at the 2024 Annual Meeting in order to ensure the Company’s compliance with the Agreement.
Effective as of the date of the Agreement, Jason Cohenour and Phu Hoang have agreed not to stand for re-election at the 2024 Annual Meeting in order to ensure the Company’s compliance with the Agreement.
On August 8, 2024, Enrike Bokuchava submitted his resignation from independent director with the Company effective immediately.
On August 7, 2024, Peter Wilver resigned from the board of directors (the “Board”) of Shoals Technologies Group, Inc. (the “Company”), effective as of August 9, 2024.
On August 7, 2024, the Board appointed, effective August 9, 2024, Niharika Taskar Ramdev as a Class I director, with a term expiring at the Company’s annual meeting of stockholders in 2025.
On August 9, 2024, Heartland Financial USA, Inc. (the “Company”) announced that Paul W. Taylor resigned from the Company’s Board of Directors effective August 7, 2024.
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.